Sentences with phrase «women at higher risk for breast cancer»

These findings suggest new indicators for identifying women at higher risk for breast cancer and provide insights into potential new strategies to detect, treat, and prevent the disease.
End cost - sharing for diagnostic imaging for breast cancer, including diagnostic mammograms, breast ultrasounds, and breast MRIs for women at high risk for breast cancer.
This rate compares favorably with hormonal treatments such as tamoxifen given as a preventive measure to women at high risk for breast cancer.
Women at high risk for breast cancer may also be screened with other imaging tests, like a breast MRI.
By Sally Chew MONDAY, Dec. 15, 2008 (Health.com)-- Women at high risk for breast cancer are generally advised to have one mammogram and one magnetic resonance image (MRI) scan every year, and they usually schedule them around the same time, along with a hands - on examination by a doctor.

Not exact matches

«Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit cancer metastasis in women with triple - negative breast cancer who are at highest risk for cancer metastasis.»
Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.
«Instead of only telling women that they don't have cancer, we could test the biopsies and tell women if they were at high risk or low risk for developing breast cancer in the future,» said Polyak, a breast cancer researcher at Dana - Farber and co-senior author of the paper.
Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27 - 30.
For some cancers like breast cancer occurring in younger women before the menopause, there even seemed to be a lower risk at higher BMI.
Launched in 1993, the Women's Health Initiative halted a Prempro test in July 2002 when researchers discovered that women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strWomen's Health Initiative halted a Prempro test in July 2002 when researchers discovered that women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strwomen taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strokes.
Seventy - five percent of women diagnosed with breast cancer have no family history or other factors that place them at high risk for the disease.
Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.
It has long been known that women with denser breasts are at higher risk for breast cancer.
«The higher risk of tumor recurrence that we observed among African American women was reduced when controlling for those factors, suggesting that these genomic differences contribute, at least partly, to the known racial disparity in the survival of African American and Caucasian breast cancer patients.»
This may help explain why women with dense breasts are also at higher risk for breast cancer.
Women who are most anxious about the possibility of developing breast cancer are least likely to attend a screening programme designed for those at high risk.
Olopade has a special interest in breast cancers that are difficult to treat and in women at high risk for this malignancy.
Until now, there has been limited information about whether it reduces breast cancer risk for women who are at the very highest level of risk with BRCA1 or BRCA2.
Presentations included: Genetics Primer & Clinical Updates by Linford Williams, MS, LGC; Genetics and Women's Health: Seeing and Foreseeing the Ethical Challenges Ahead by Ruth Farrell, MD, MA; Preimplantation Genetic Screening and Diagnosis: What You Need to Know by Marissa Coleridge, MS, LGC; Evolution of Prenatal Genetic Screening and Testing: NIPT and Beyond by Jeff Chapa, MD, MBA; Promises and Pitfalls of Prenatal Whole Exome Sequencing by Amanda Kalan, MD; Fertility Preservation and Cancer: Survivors, Previvors, and the Newly Diagnosed by Rebecca Flyckt, MD; Improving Access to Cancer Genetics via Telegenetics by Ryan Noss, MS, LGC; Breast Cancer: Management of Moderate Penetrance Predisposition Genes by Holly Pederson, MD; Use of Hormonal and Non-hormonal Therapies in Breast Cancer Survivors and Women at High Risk for Breast / Gyn Cancers by Holly Thacker, MD; Addressing Commonly Asked Patient Questions about Genetics by Rebekah Moore, MS, LGC, Christina Rigelsky, MS, LGC and Allison Schreiber, MS, LGC; and a panel discussion on Genetic Testing Reimbursement featuring Bruce Rogen, MD, MPH and John Yao, MD, MBA, MPH, which was moderated by Daniel Sullivan, MD..
Now, a study published in the August 2014 issue of Cancer Research states that women taking birth control pills are at higher risk for breast cancer, and that the risk depends on the amount of estrogen in that particularCancer Research states that women taking birth control pills are at higher risk for breast cancer, and that the risk depends on the amount of estrogen in that particularcancer, and that the risk depends on the amount of estrogen in that particular pill.
• Limit alcohol to one drink per day (women who are at high risk for breast cancer should consider not drinking alcohol at all).
More Evidence that Vitamin D Protects Against Breast Cancer A new study shows that women with low vitamin D levels are at a higher risk for breast cancer, but women on HRT aren't as well protBreast Cancer A new study shows that women with low vitamin D levels are at a higher risk for breast cancer, but women on HRT aren't as well protCancer A new study shows that women with low vitamin D levels are at a higher risk for breast cancer, but women on HRT aren't as well protbreast cancer, but women on HRT aren't as well protcancer, but women on HRT aren't as well protected.
Research shows healthy women at high risk of breast cancer who took the medication for four - and - a-half years lowered their breast density by 6.4 percent, Diorio relates.
It was Lindsay's hope to turn her experiences as a young woman at high risk for breast and ovarian cancer into a resource and supportive community for other young women.
It was during my journey that I realized the lack of resources for women in my specific situation — young women who weren't survivors but were at high risk for developing breast and ovarian cancer and those who wanted to take charge of their health.
There were so many resources for breast and ovarian cancer survivors but none specifically for young women at high - risk.
a b c d e f g h i j k l m n o p q r s t u v w x y z